Home » NAFDAC Newsroom
NAFDAC Newsroom
The list below provides information gathered from press releases and other public notices of The Agency
Highlights
-
Launch of the Implementation of Strategy and Roadmap for Trans-fatty Acids (TFAs) Regulation
-
List of Withdrawn, Suspended and Cancelled products as approved by NAFDAC
-
Updated Public Alert No. 030A/2025 - Sale of Confirmed Substandard ARTEMETRIN DS Tablets
-
Public Alert No. 030B/2025 - Sale of Confirmed Falsified CIPROFIT 500
-
Public Alert No. 029/2025 – Notice to Recall Embacef 125 Powder For Oral Suspension
-
Public Alert No. 028/2025 – Alert on Unregistered/Falsified Oxytocin Injection
News
- Press Announcements
- Speeches
- Events
- Approvals
- Warning Letters
- Notes to Industries
- Recalls & Alerts
- Testimony
Profile & Photos
Quick Links
- Approval of NAFDAC Regulated Products
- Freedom of Information
Events
- NAFDAC Meetings Conferences & Workshops
- Campus Tours
- Sensitization
- Content Current as of January 22, 2024
More Actions
Was this helpful?
Yes
No
Thanks for your feedback!